660 related articles for article (PubMed ID: 7450397)
1. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
[TBL] [Abstract][Full Text] [Related]
2. Drug metabolism in adult rat hepatocytes in primary monolayer culture.
Guzelian PS; Bissell DM; Meyer UA
Gastroenterology; 1977 Jun; 72(6):1232-9. PubMed ID: 404208
[TBL] [Abstract][Full Text] [Related]
3. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats.
Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K
Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867
[TBL] [Abstract][Full Text] [Related]
4. Hepatic microsomal mixed-function oxidases in rats exposed to high ambient temperature.
Pachecka J; Kobylińska K; Miaskiewicz H; Bicz W
Acta Physiol Pol; 1983; 34(5-6):563-8. PubMed ID: 6679992
[TBL] [Abstract][Full Text] [Related]
5. Effect of Schistosoma mansoni infection on the hepatic drug-metabolizing capacity of mice.
Cha YN; Edwards R
J Pharmacol Exp Ther; 1976 Nov; 199(2):432-40. PubMed ID: 185361
[TBL] [Abstract][Full Text] [Related]
6. Contrasting effect of isoflurane on drug metabolism: decreased type I and increased type II substrate metabolism in guinea pig liver microsomes.
Rahman MM; Fujii K; Kawamoto M; Yuge O
J Appl Toxicol; 1996; 16(4):331-7. PubMed ID: 8854220
[TBL] [Abstract][Full Text] [Related]
7. [State of the microsomal oxidative system of the rat liver in acute intestinal obstruction].
Krakovskiĭ ME; Ashirmetov AKh; Komarin AS; Faĭngol'd DIa
Vopr Med Khim; 1988; 34(3):117-20. PubMed ID: 3420799
[TBL] [Abstract][Full Text] [Related]
8. Lack of in vitro and in vitro effects of fenbendazole on phase I and phase II biotransformation enzymes in rats, mice and chickens.
Dalvi RR; Gawai KR; Dalvi PS
Vet Hum Toxicol; 1991 Dec; 33(6):548-51. PubMed ID: 1808827
[TBL] [Abstract][Full Text] [Related]
9. [Effect of benzodiazepines on drug-metabolizing enzymes. II. Increased environmental temperature as a modifier of the effect of nitrazepam on microsomal monooxygenases of the rat liver].
Pachecka J; Kobylińska K; Brozyna M; Bicz W
Acta Pol Pharm; 1988; 45(3):271-5. PubMed ID: 3239430
[No Abstract] [Full Text] [Related]
10. Postnatal development of mixed-function oxidation as measured in microsomes from the small intestine and liver of rabbits.
Tredger JM; Chhabra RS; Fouts JR
Drug Metab Dispos; 1976; 4(1):17-24. PubMed ID: 3396
[TBL] [Abstract][Full Text] [Related]
11. Effects of model traumatic injury on hepatic drug metabolism in the rat. III. Differential responses of cytochrome P-450 subpopulations.
Griffeth LK; Rosen GM; Rauckman EJ
Drug Metab Dispos; 1984; 12(5):588-95. PubMed ID: 6149909
[TBL] [Abstract][Full Text] [Related]
12. Hepatic microsomal drug metabolism, glutamyl transferase activity and in vivo antipyrine half-life in rats chronically fed an ethanol diet, a control diet and a chow diet.
Gadeholt G; Aarbakke J; Dybing E; Sjöblom M; Mørland J
J Pharmacol Exp Ther; 1980 Apr; 213(1):196-203. PubMed ID: 6102148
[TBL] [Abstract][Full Text] [Related]
13. Effect of "drugs for liver disease" on hepatotoxic action of carbon tetrachloride. II. Effect of protoporphyrin and phosphorylcholine on microsomal drug-metabolizing enzyme activities and the components in injuried liver.
Ogiso T; Kobayashi T; Kuhara K; Kato Y
Jpn J Pharmacol; 1975 Aug; 25(4):411-21. PubMed ID: 813044
[TBL] [Abstract][Full Text] [Related]
14. Role of neonatal androgen in the development of hepatic microsomal drug-metabolizing enzymes.
Chung LW; Raymond G; Fox S
J Pharmacol Exp Ther; 1975 May; 193(2):621-30. PubMed ID: 1142108
[TBL] [Abstract][Full Text] [Related]
15. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT
Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054
[TBL] [Abstract][Full Text] [Related]
16. Maturational development of drug-metabolizing enzymes in sheep.
Kawalek JC; el Said KR
Am J Vet Res; 1990 Nov; 51(11):1736-41. PubMed ID: 2240798
[TBL] [Abstract][Full Text] [Related]
17. [Hepatic microsomal monoxygenase inhibition by nabam in the rat (author's transl)].
Périquet A; Derache R
Toxicol Eur Res; 1981 Nov; 3(6):285-91. PubMed ID: 7330871
[TBL] [Abstract][Full Text] [Related]
18. Effect of nicotinamide administration to rats on the liver microsomal drug metabolizing enzymes.
Nomura K; Shin M; Sano K; Umezawa C; Shimada T
Int J Vitam Nutr Res; 1983; 53(1):36-43. PubMed ID: 6222007
[TBL] [Abstract][Full Text] [Related]
19. [Studies on correlation between liver drug metabolizing enzyme activities and microsomal membrane fluidity in phenobarbital treated rats].
Fu LS; Peng RX
Yao Xue Xue Bao; 1991; 26(8):567-71. PubMed ID: 1805518
[TBL] [Abstract][Full Text] [Related]
20. [Effect of N-ethyl-N-nitrosourea on the liver ultrastructure. I. Activity of the cytochrome P-450-dependent hepatic monooxygenase system].
Kamiński M; Plewka A; Plewka D; Gaździk T; Czechowicz K; Urbańska D
Med Pr; 1986; 37(1):12-21. PubMed ID: 3088382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
